دانلود کتاب راهنمای جیبی داروساز برای دیابت و چاقی

An estimated 529 million people live with all forms of diabetes, according to analysis prepared for the Global Burden of Disease Study 2021. This equates to a global age-adjusted prevalence level of 6.1%. Of the known types of diabetes, type 2 diabetes (T2D) contributes to most cases, with 96% of all cases globally being diagnosed as T2D [6]. The prevalence of diabetes has grown consistently across the globe since the 1990s, and 2050 projections show no meaningful decline in its growth with over 1.3 billion people projected to live with diabetes and global prevalence rate near 10% [1, 6]. In the United States (US), the Centers for Disease Control and Prevention estimates a total of 38.1 million adults diagnosed with diabetes, or 11.3% of the US population, with approximately 8.7 million of those being undiagnosed [ 7]. On top of the substantial number of individuals estimated to have diabetes, another 97.6 million adults, or 38% of the US adult population, are estimated to have prediabetes [ 7]. Prediabetes is a recognizable state that identifies individuals at risk of developing T2D [ 8]. While T2D is the predominant form of diabetes, pharmacists and providers must be aware of all known forms given the risk of misdiagnosis followed by the potential for inappropriate therapy. Of other known types, the most common are type 1 diabetes (T1D) and gestational diabetes (GD). In the United States an estimated 5.7% of individuals report having T1D, and GD is diagnosed in 8.3% of adult individuals giving birth [ 5]. Other forms include monogenic diabetes syndromes or maturity-onset diabetes of the young (MODY), with estimates of 1–5% of the total diabetes population; drug-induced diabetes, with variable rates and impact depending on the offending agent; and diseases of the exocrine pancreas (e.g., pancreatitis, cystic fibrosis, neoplasms) [ 9].